Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Veradigm, an EMR company with a billion-dollar market cap until recently, is facing challenges with delayed financial filings, potential delisting from NASDAQ, and shareholder concerns following CEO and CFO resignations. The company's stock is set to be suspended from NASDAQ, leading to forced selling by passive holders.
Btw, folks should pay attention to how this $MDRX ScienceIO deal plays out over time. There are imo only a handful of scenarios where incinerating $140m of $232m net cash (est) under these circumstances makes any ("dark arts") sense...and they're all egregious. Something smells https://t.co/3clWLFa6ZJ https://t.co/SJk6KoU3am
Bleecker Street is short Veradigm $MDRX, an EMR company that has been unable to file financials since Q3’22. The NASDAQ will suspend the MDRX's common stock tomorrow. Russell 2000 has to sell 17 million shares, other passive holders could be forced to sell.
Looks fair, the rest are more ludicrous... ...but #ARB's more dangerous, boasting a $146M mkt cap despite its debt trading at 35 cts/$ & its FY results* likely to confirm it went insolvent THREE times last year! *Alas, FY results only due end-April...jst after the #halving! 😳 https://t.co/9OsV2H2aVP